Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John Bridgewater

Showing results (121-130 of 124) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 124 results.
Genome Research|May 27, 2011
A DNA methylation fingerprint of 1628 human samplesAgustin F Fernandez, Yassen Assenov, Jose Ignacio Martin-Subero, et al.
The Lancet. Gastroenterology & Hepatology|May 14, 2019
Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer: the prospective Streamline C trialStuart A Taylor, Sue Mallett, Sandy Beare, et al.
JHEP Reports : Innovation in Hepatology|March 1, 2021
Assessing the impact of COVID-19 on liver cancer management (CERO-19)Sergio Muñoz-Martínez, Victor Sapena, Alejandro Forner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 28, 2015
Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset, Josef Thaler, Richard Greil, et al.
Pageof 13

Showing results (121-130 of 124) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 124 results.
Genome Research|May 27, 2011
A DNA methylation fingerprint of 1628 human samplesAgustin F Fernandez, Yassen Assenov, Jose Ignacio Martin-Subero, et al.
The Lancet. Gastroenterology & Hepatology|May 14, 2019
Diagnostic accuracy of whole-body MRI versus standard imaging pathways for metastatic disease in newly diagnosed colorectal cancer: the prospective Streamline C trialStuart A Taylor, Sue Mallett, Sandy Beare, et al.
JHEP Reports : Innovation in Hepatology|March 1, 2021
Assessing the impact of COVID-19 on liver cancer management (CERO-19)Sergio Muñoz-Martínez, Victor Sapena, Alejandro Forner, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 28, 2015
Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset, Josef Thaler, Richard Greil, et al.
Pageof 13